News NHS may double subscription rate for novel antibiotics The yearly subscription-style payments made by NHS England to developers of novel antibiotics could be doubled from £10 million to £20 million in some cases, according to
Oncology ASCO 2023 – Dr Lalan Wilfong In the last video from ASCO 2023, we step away from the R&D side to talk about drug costs and payment models.
Market Access What happened to all the antibiotics? Across the world, there are reports of shortages of common antibiotics.
Digital Chaos & opportunity: Dr Adam Brown unpacks US health policy Dive into our video interview with Dr Adam Brown as he unpacks the chaos and opportunity shaping US health policy.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face